Atlas Trials

Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

Clinical trial NCT02739100 · COMPLETED

Trial details

NCT number
NCT02739100
Sponsor
Rockwell Medical Technologies, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
End Stage Renal Disease
Start date
2016-04-01
Primary completion
2016-07-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.